← Back
$AMLX All transactions

Amylyx Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$125K

Shares

15,000

Price

$8

Filed

Aug 14

Insider

Name

Mazzariello Gina

Title

Chief Legal Officer

CIK

0001913765

Roles

Officer

Transaction Details

Transaction Date

2025-08-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

156,969

Footnotes

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.82 to $8.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.13 to $8.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Filing Info

Accession No.

0000950170-25-108912

Form Type

4

Issuer CIK

0001658551

Mazzariello Gina's History

Date Ticker Type Value
2026-03-05 AMLX A $0
2026-03-05 AMLX A $0
2026-03-02 AMLX $99K
2026-02-23 AMLX $48K
2026-02-02 AMLX $51K
2025-09-30 AMLX $129K
2025-08-13 AMLX $125K
2025-08-12 AMLX $121K
2025-05-22 AMLX G $0

Other Insiders at AMLX (90d)

Insider Bought Sold Last
FRATES JAMES M
Chief Financial Officer
$167K 2026-03-05
Bedrosian Camille L
Chief Medical Officer
$94K 2026-03-05
Klee Justin B.
Co-Chief Executive Officer
$651K 2026-03-05
Cohen Joshua B
Co-Chief Executive Officer
$652K 2026-03-05
Mazzariello Gina
Chief Legal Officer
$198K 2026-03-05